Merkel cell carcinoma: Identification of prognostic factors unique to tumors located in the head and neck based on analysis of SEER data

Laryngoscope

Volumn 122, Issue 6, 2012, Pages 1283-1290

  Smith, Valerie A ^a   Camp, E Ramsay ^a,b   Lentsch, Eric J ^a,b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

cutaneous malignancies; elderly; head and neck; Merkel cell carcinoma; prognostic factors

Indexed keywords

ADULT; AGED; BIBLIOGRAPHIC DATABASE; CANCER EPIDEMIOLOGY; CANCER LOCALIZATION; CANCER PROGNOSIS; CANCER REGISTRY; CANCER SURVIVAL; CONFERENCE PAPER; CONTROLLED STUDY; DERMIS; DISEASE ASSOCIATION; DISEASE MARKER; DISEASE SPECIFIC SURVIVAL; DISTANT METASTASIS; FEMALE; HEAD AND NECK CARCINOMA; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; MERKEL CELL TUMOR; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEX RATIO;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CARCINOMA, MERKEL CELL; COMBINED MODALITY THERAPY; DATABASES, FACTUAL; DISEASE-FREE SURVIVAL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; KAPLAN-MEIER ESTIMATE; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEER PROGRAM; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; UNITED STATES;

EID: 84861793441     PISSN: 0023852X     EISSN: 15314995     Source Type: Journal    
DOI: 10.1002/lary.23222     Document Type: Conference Paper

References (26)

1. Engels EA, Frisch M, Goedert JJ, Biggar RJ, Miller RW,. Merkel cell carcinoma and HIV infection. Lancet 2002; 359: 497-498.
2. Penn I, First MR,. Merkel's cell carcinoma in organ recipients: report of 41 cases. Transplantation 1999; 68: 1717-1721.
3. Agelli M, Clegg LX,. Epidemiology of primary Merkel cell carcinoma in the United States. J Am Acad Dermatol 2003; 49: 832-841. Erratum in: J Am Acad Dermatol 2004;50:733.
4. Hodgeson NC,. Merkel cell carcinoma: Changing incidence trends. J Surg Oncol 2005; 89: 1-4.
5. Pellitteri PK, Takes RP, Lewis JS, et al. Merkel cell carcinoma of the head and neck. Head Neck 2011. doi: 10.1002/hed.21787.
6. Yiengpruksawan A, Coit DG, Thaler HT, Urmacher C, Knapper WK,. Merkel cell carcinoma. Prognosis and management. Arch Surg 1991; 126: 1514-1519.
7. Schmalbach CE, Lowe L, Teknos TN, Johnson TM, Bradford CR,. Reliability of sentinel lymph node biopsy for regional staging of head and neck Merkel cell carcinoma. Arch Otolaryngol Head Neck Surg 2005; 131: 610-614.
8. Allen PJ, Browne WB, Jaques DP, et al. Merkel cell carcinoma: Prognosis and treatment of patients from a single institution. J Clin Oncol 2005; 23: 2300-2309.
9. Gillenwater AM, Hessel AC, Morrison WH, et al. Merkel cell carcinoma of the head and neck: effect of surgical excision and radiation on recurrence and survival. Arch Otolaryngol Head Neck Surg 2001; 127: 149-154.
10. Hoersch B, Leiter U, Garbe C,. Is head and neck melanoma a distinct entity? A clinical registry-based comparative study in 5702 patients with melanoma. Brit J Dermatol 2006; 155: 771-777.
11. Gillgren P, Mansson-Brahme E, Frisell J, Johansson H, Larsson O, Ringborg U,. A prospective population-based study of cutaneous malignant melanoma of the head and neck. Laryngoscope 2000; 110: 1498-1504.
12. Wagner JD, Park HM, Coleman JJ 3rd, Love C, Hayes JT,. Cervical sentinel lymph node biopsy for melanomas of the head and neck and upper thorax. Arch Otolaryngol Head Neck Surg 2000; 126: 313-321.
13. Golger A, Young DS, Ghazarian D, Neligan PC,. Epidemiological features and prognostic factors of cutaneous head and neck melanoma: a population-based study. Arch Otolaryngol Head Neck Surg 2007; 133: 442-447.
14. National Cancer Institute. SEER brochure. NIH Publication No. 05-4772. September 2005. Available at:. Accessed on April 15, 2011.
15. American Joint Committee on Cancer. AJCC Cancer Staging Manual. 7th ed. New York: Springer; 2010.
16. Andea AA, Coit DG, Amin B, Busam KJ,. Merkel cell carcinoma: histologic features and prognosis. Cancer 2008; 113: 2549-2558.
17. Sandel HD 4th, Day T, Richardson MS, Scarlett M, Gutman KA,. Merkel cell carcinoma: does tumor size or depth of invasion correlate with recurrence, metastasis, or patient survival? Laryngoscope 2006; 116: 791-795.
18. Kukko H, Bohling T, Koljonen V, et al. Merkel cell carcinoma-A population-based epidemiological study in Finland with a clinical series of 181 cases. Eur J Cancer 2012; 48: 737-742.
19. Fields RC, Busam KJ, Chou JF, et al. Recurrence and survival in patients undergoing sentinel lymph node biopsy for merkel cell carcinoma: analysis of 153 patients from a single institution. Ann Surg Oncol 2011; 18: 2529-2537.
20. Ng L, Beer TW, Murray K,. Vascular density has prognostic value in Merkel cell carcinoma. Am J Dermatopathol 2008; 30: 442-445.
21. Lemos BD, Storer BE, Iyer JG, et al. Pathologic node evaluation improves prognostic accuracy in Merkel cell carcinoma: analysis of 5823 cases as the basis of the first consensus staging system. J Am Acad Dermatol 2010; 63: 751-761.
22. Smith DE, Beilamowicz S, Kagan AR, Anderson PJ, Peddada AV,. Cutaneous neuroendocrine (Merkel cell) carcinoma: A report of 35 cases. Am J Clin Oncol 1995; 18: 199-203.
23. The National Comprehensive Cancer Network. Clinical practice guidelines in oncology. Merkel cell carcinoma. Version 2.2011. Available at:. Accessed on June 20, 2011.
24. Mehrany K, Otley CC, Weenig RH, Phillips PK, Roenigk RK, Nguyen TH,. A meta-analysis of the prognostic significance of sentinel lymph node status in Merkel cell carcinoma. Dermatol Surg 2002; 28: 113-117.
25. Warner RE, Quinn MJ, Hruby G, Scolyer RA, Uren RF, Thompson JF,. Management of merkel cell carcinoma: the roles of lymphoscintigraphy, sentinel lymph node biopsy and adjuvant radiotherapy. Ann Surg Oncol 2008; 15: 2509-2518.
26. Bajetta E, Celio L, Platania M, et al. Single institution series of early-stage Merkel cell carcinoma: long-term outcomes in 95 patients managed with surgery alone. Ann Surg Oncol 2009; 16: 2985-2993.